Evidence-Based Intervention: Attention Deficit Hyperactivity Disorder
Hello and Welcome to Week 3,
1. For this week's assignment, you will select a specific disorder for you to research for this assignment.
2. Use the Walden library to research evidence-based treatments for your assigned disorder in children and adolescents. You will need to recommend one FDA-approved drug, one off-label drug, and one non-pharmacological intervention for treating this disorder in children and adolescents.
Here are a few childhood mental disorders that may be of interest.
Anxiety Disorder in Children
Depression in Children
Oppositional Defiant Disorder (ODD)
Conduct Disorder (CD)
Attention Deficit Hyperactivity Disorder (ADHD)
Tourettes Syndrome
Obsessive-Compulsive Disorder (OCD)
Post Traumatic Stress Disorder (PTSD)
What disorder have you seen in your clinical setting that you would like to explore more deeply?
Dr. Pinckney
Your Instructor will assign a specific disorder for you to research for this Assignment.
Use the Walden library to research evidence-based treatments for your assigned disorder in children and adolescents. You will need to recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating this disorder in children and adolescents.
The Assignment (1–2 pages)
Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your assigned disorder in children and adolescents.
Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.
Evidence-Based Intervention – Attention Deficit Hyperactivity Disorder
Your Name
Subject and Section
Professor's Name
March 22, 2021
Understanding the importance of Evidence-based intervention in the treatment of illnesses is essential for any healthcare provider. It allows him to understand better how to utilize the new technologies, techniques, and other healthcare provision methods. In this article, the author would like to focus on the various evidence-based practices studied and implemented in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) among children. The evidence-based treatments that would be discussed are examples of an FDA-approved drug, an off-label drug, and a non-pharmacological treatment for the said disorder. All in all, the author believes that by understanding the differences between these three, it becomes possible for any healthcare provider to ensure the best treatment for children with ADHD.
Treatments
An example of an FDA-approved drug for treating ADHD is methylphenidate. Methylphenidate, also commonly known as 'Ritalin,' is a first line psychostimulant medication used to treat children with ADHD. Being an FDA-approved drug, this medication has been tested and confirmed by regulatory bodies and government agencies to be safe for its intended use. For example, in one study by Gerlach et al. (2017), the authors noted that a systematic review of methylphenidate has helped improve the management and reduce ADHD symptoms. Additionally, the authors noted that distal outcomes usually triggered and caused by ADHD have been reduced, such as "a reduction in comorbid depression, substance-use and dependency, trauma-related visits to the emergency room and mortality." This suggests that this FDA-approved drug is beneficial, not only for reducing the symptoms of the disease for children but also for other adverse outcomes that might arise with hyperactivity.
Another example of a treatment that is used for ch...